Centro Emiliano Ricerche Biomediche

What Centro Emiliano Ricerche Biomediche does

Centro Emiliano Ricerche Biomediche (CERB) is a small Italian entity registered in Parma, in the Emilia-Romagna region. Based on its Italian name, which translates to "Emilian Center for Biomedical Research," the organization appears to be positioned as a biomedical research center operating within the Emilian research ecosystem. The company reports a headcount of 5 employees, indicating a micro-scale operation. Its public web presence is currently limited: the website at cerb.it returned only a loading/verification page with no substantive corporate, programmatic, or scientific content, and no social profiles, app listings, or API endpoints are documented in the source material.

No product portfolio, service offerings, technology stack, proprietary features, or integration partnerships are disclosed in the available data. There is no evidence of funding rounds, investors, subsidiaries, M&A activity, regulatory actions, certifications, patents, trademarks, or recognized awards. The company type, founding date, legal entity form, ownership structure, and operating geographies are all unspecified in the source data.

No revenue, pricing model, or go-to-market motion is disclosed. There are no named customers, customer segments, distribution channels, or marketing channels documented. The operating status is marked as "operating" per the source record, but no management team is identified and no contact details beyond the website URL are available. In summary, CERB presents as a small, low-disclosure biomedical research-oriented entity in Parma with minimal verifiable operational signal in the public data set.

Name

Centro Emiliano Ricerche Biomediche

Website

https://cerb.it

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Centro Emiliano Ricerche Biomediche (CERB) is a 5-employee biomedical research entity based in Parma, Italy. The organization operates with minimal public disclosure, and its website provides no substantive corporate or programmatic content beyond a verification page.

Ownership category

akta.pro rank

Product category

Biomedical Research

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)

akta.pro secondary industry

Material Characterization & Spectroscopy (NMR/FTIR/MS) (HLAGADAK)

Keywords

• Biomedical research
• Life sciences research
• Clinical research services
• Medical research center
• Health sciences research

GTM type

B2B

Offering type

Services

Core offering

Based on the firm name, Centro Emiliano Ricerche Biomediche appears to be a biomedical research entity, but no specific details on its core offerings, product lines, or service scope are available in the provided source data. The company website returned only a loading/verification page with no substantive content.

Differentiator

Problem solved

Functional benefit

Products and services

• Biomedical research services Based on the company name and location, the firm appears to be a biomedical research organization, but no specific service descriptions are available in the provided source data.

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Emerging players

• Istituto Italiano di Tecnologia (IIT): Italian public research foundation performing translational biomedical and life-science research across multiple sites. Comparable as an Italy-based biomedical research entity, although it is a public, non-profit research institute rather than a private services firm.

Regional players

• Chiesi Farmaceutici S.p.A. Parma-headquartered global pharmaceutical company with significant in-house biomedical R&D and clinical manufacturing. Comparable as a same-city biomedical R&D anchor; Chiesi is a potential client or partner rather than a direct services competitor given its sponsor-side focus.

Direct peers

• IRBM S.p.A. Italian biomedical research organization located near Rome that performs integrated drug discovery, including biology, chemistry and ADME/PK services. Directly comparable as an Italian-headquartered contract biomedical research entity, though materially larger in headcount and scope.
• Nerviano Medical Sciences S.r.l. Italy-based oncology-focused drug discovery and preclinical research organization that performs biomedical chemistry and biology research for partners. Comparable as an Italian-headquartered biomedical R&D services firm, with an oncology specialization that is more focused than the broad 'biomedical research' positioning of the subject company.

Broad incumbents

• Eurofins Scientific SE: Global leader in bioanalytical and laboratory testing services, including pharmaceutical and biomedical contract testing. Comparable as a large-scale incumbent in the same outsourced life-sciences testing category the Centro likely operates in, though Eurofins is multi-continent and far broader in scope.
• Evotec SE: Hamburg-headquartered contract research and drug discovery platform serving pharma and biotech with biology, chemistry, and integrated R&D services. Comparable as a European CRO with a much broader scientific service portfolio than the subject firm.
• Charles River Laboratories International, Inc. Global CRO offering biomedical research models, safety assessment, and laboratory services to pharma and biotech. Comparable as an established incumbent in contract biomedical research services, operating at vastly larger scale than the subject company.
• Accelera (CRO) — Aptuit/SGS: European-based preclinical CRO providing ADME, bioanalysis and pharmacology services to pharma. Comparable as a Europe-based contract biomedical research services provider operating at materially greater scale than the subject firm.

Market position

Strengths3 records

Weaknesses4 records

Key risks4 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/centro-emiliano-ricerche-biomediche

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centro Emiliano Ricerche Biomediche